The following table details the insider trading activities
(stock purchases, stock sales, and stock option exercises) of Doyle Janeen Noel since 2026.
This trader's CIK number is 2069239.
At the time of last reporting, Doyle Janeen Noel was the Chief Corp. & Bus. Dev. Ofcr of Janux Therapeutics, Inc.. (stock ticker symbol JANX).
Also see all insider trading activities at Janux Therapeutics, Inc..
| Insider Buying | Insider Sales | Option Exercises | |||||
|---|---|---|---|---|---|---|---|
| Year | Symbol | Shares | Value | Shares | Value | Shares | Value |
| 2026 | JANX | 0 | $0 | 4,059 | $56,943 | 0 | $0 |
| Trade Date | Symbol | Trade Type | Shares | Price ($) | Value ($) |
|---|---|---|---|---|---|
| 2026-06-02 | JANX | Sale | 4,059 | 14.03 | 56,943 |
Insider trading activities including stock purchases, stock sales, and option exercises listed in the above table cannot be completely guaranteed as to their accuracy. For more information regarding the trades made by Doyle Janeen Noel (Chief Corp. & Bus. Dev. Ofcr of Janux Therapeutics, Inc. at the time of this reporting) see the Securities and Exchange Commission (SEC) website.